Related Experiment Video
Updated: Feb 9, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer
Fengtian Wang1, Sweaty Koul2,3, Prakash S T Shanmugam1
1Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, Louisiana.
Abstract:
Metastasis is the primary cause of prostate cancer morbidity and mortality. Our previous studies revealed that Sam pointed domain ETS transcription factor, a.k.a. prostate-derived ETS factor (SPDEF/PDEF), inhibits prostate cancer metastasis. However, the mechanism is still unclear. In this study, using microarray and gene set enrichment analysis, we discovered that PDEF upregulated epithelial/luminal differentiation-related genes while it suppressed stemness and epithelial-to-mesenchymal transition-related genes, especially Twist1. We also observed loss of PDEF and gain of Twist1 expression during prostate cancer progression in the TRAMP mouse model. Moreover, Twist1 knockdown resulted in upregulation of PDEF expression, suggesting a reciprocal regulation between PDEF and Twist1. Mechanistically, our ChIP-seq analysis revealed that PDEF directly regulated cytokeratin 18 (CK18) transcription through the GGAT motif within its putative promoter region. CK18 knockdown resulted in increased expression of Twist1, suggesting that PDEF regulated Twist1 in part via CK18. Our analysis of multiple clinical prostate cancer cohorts revealed an inverse relationship between PDEF expression and tumor grade, tumor metastasis, and poor patient survival. Furthermore, a two-gene signature of low PDEF and high Twist1 can better predict poor survival in prostate cancer patients than either gene alone. Collectively, our findings demonstrate PDEF inhibits prostate tumor progression, in part, by directly regulating transcription of CK18, and that PDEF/Twist1 expression could help distinguish between lethal and indolent prostate cancer.Implications: This study reports the novel findings that PDEF suppresses Twist1 partly via CK18 and that PDEF/Twist1 could help distinguish between lethal and indolent prostate cancer.Visual Overview: http://mcr.aacrjournals.org/content/molcanres/16/9/1430/F1.large.jpg Mol Cancer Res; 16(9); 1430-40. ©2018 AACR.
Insights
Prostate cancer metastasis is inhibited by SPDEF/PDEF, which suppresses stemness and EMT via Twist1 and CK18. PDEF/Twist1 levels can predict lethal versus indolent prostate cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Prostate cancer metastasis is a major cause of mortality.
- Sam pointed domain ETS transcription factor (SPDEF/PDEF) inhibits prostate cancer metastasis, but the mechanism is unclear.
Purpose of the Study:
- To elucidate the mechanism by which PDEF inhibits prostate cancer metastasis.
- To investigate the relationship between PDEF, Twist1, and cytokeratin 18 (CK18) in prostate cancer progression.
- To evaluate the prognostic value of PDEF and Twist1 in prostate cancer patients.
Main Methods:
- Microarray and gene set enrichment analysis to identify PDEF-regulated genes.
- Analysis of the TRAMP mouse model for PDEF and Twist1 expression changes during cancer progression.
- Chromatin immunoprecipitation sequencing (ChIP-seq) to identify PDEF direct targets.
- Knockdown experiments (Twist1 and CK18) to assess functional relationships.
- Analysis of clinical prostate cancer cohorts.
Main Results:
- PDEF upregulates epithelial differentiation genes and suppresses stemness and epithelial-to-mesenchymal transition (EMT) genes, notably Twist1.
- PDEF expression is lost while Twist1 expression is gained during prostate cancer progression in TRAMP mice.
- PDEF directly regulates CK18 transcription; CK18 knockdown increases Twist1 expression, indicating PDEF regulates Twist1 partly via CK18.
- PDEF expression is inversely correlated with tumor grade, metastasis, and poor survival.
- A PDEF/Twist1 signature predicts poor survival more effectively than either gene alone.
Conclusions:
- PDEF inhibits prostate tumor progression and metastasis, partly through direct regulation of CK18, which in turn influences Twist1 expression.
- The PDEF/Twist1 axis represents a novel mechanism in prostate cancer progression.
- PDEF and Twist1 expression levels can serve as biomarkers to distinguish between lethal and indolent prostate cancer.
More Related Videos
07:21Establishment and Analysis of Three-Dimensional 3D Organoids Derived from Patient Prostate Cancer Bone Metastasis Specimens and their Xenografts
Published on: February 3, 2020
10:38Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Published on: November 22, 2019
Related Concept Videos
Feedback Inhibition
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Transcription Factors
Induced Pluripotent Stem Cells
Mechanisms of Retrovirus-induced Cancers
Measurement: Derived Units